| Full text | |
| Author(s): |
Brunaldi, Mariangela Ottoboni
[1]
;
Costa Silva, Rene Julias
[1]
;
Fabro, Alexandre Todorovic
[1]
;
de Almeida e Araujo, Daniel Cardoso
[2]
;
Basile-Filho, Anibal
[3]
;
Auxiliadora-Martins, Maria
[3]
;
Menegueti, Mayra Goncalves
[3]
;
Beloddi, Maria Isabel
[3]
;
Alves Esposito, Danillo Lucas
[4]
;
Lopes da Fonseca, Benedito Antonio
[4]
Total Authors: 10
|
| Affiliation: | [1] Univ Sao Paulo, Univ Hosp, Ribeirao Preto Med Sch, Dept Pathol & Forens Med, USP, Ribeirao Preto, SP - Brazil
[2] Secretaria Municipal Saude, Div Epidemiol Surveillance, Ribeirao Preto, SP - Brazil
[3] Univ Sao Paulo, Div Intens Care Med, Ribeirao Preto Med Sch, Dept Surg & Anat, Univ Hosp, USP, Ribeirao Preto, SP - Brazil
[4] Univ Sao Paulo, Infect Dis Div, Ribeirao Preto Med Sch, Dept Internal Med, Univ Hosp, USP, Ribeirao Preto, SP - Brazil
Total Affiliations: 4
|
| Document type: | Journal article |
| Source: | American Journal of Tropical Medicine and Hygiene; v. 105, n. 6, p. 1803-1805, DEC 2021. |
| Web of Science Citations: | 0 |
| Abstract | |
Yellow fever is a viral hemorrhagic disease, and vaccination is the most effective way to minimize the impact of the disease. Serious adverse events after yellow fever vaccination are rare. We report the case of a young woman with an unusual presentation of yellow fever 17DD vaccine-associated acute viscerotropic disease, with severe hepatic impairment following a long incubation period. She died more than a month after yellow fever vaccination. (AU) | |